المؤلفون: Tian J; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Song YP; The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China., Zhang GC; Yifan Research & Development, Hefei, Anhui, China., Wang SF; Yifan Research & Development, Hefei, Anhui, China., Chu XX; Yifan Research & Development, Hefei, Anhui, China., Chai Y; Lanzhou University Second Hospital, Lanzhou, Gansu, China., Wang CL; The Affiliated Huaian No 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, China., He AL; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Zhang F; The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China., Shen XL; Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China., Zhang WH; The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China., Yang LH; The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China., Nie DN; The Second Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China., Wang DM; Hengshui People's Hospital, Hengshui, Hebei, China., Zhu HL; West China Hospital of Sichuan University, Chengdu, Sichuan, China., Gao D; The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China., Lou SF; The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China., Zhou ZP; The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China., Su GH; Cangzhou Central Hospital, Cangzhou, Hebei, China., Li Y; The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China., Lin JY; The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China., Shi QZ; The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China., Ouyang GF; Ningbo First Hospital, Ningbo, Zhejiang, China., Jing HM; Peking University Third Hospital, Beijing, China., Chen SJ; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. sjchen@stn.sh.cn., Li J; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Nclijian@163.com., Mi JQ; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jianqingmi@shsmu.edu.cn.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Apr 11; Vol. 150 (4), pp. 189. Date of Electronic Publication: 2024 Apr 11.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/adverse effects , Arsenic*/therapeutic use , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy, Humans ; Imatinib Mesylate/adverse effects ; Pandemics ; Treatment Outcome

المؤلفون: Li J; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China., Qin S; Department of Oncology, Cancer Center of Jinling Hospital, Nanjing University of Chinese Medicine, No. 34 Biao, 34 Hao, Yanggongjing Road, Qinhuai District, Nanjing, 210002, Jiangsu Province, China. qinsk@csco.org.cn., Wen L; Department of Gastroenterology, Shanxi Provincial Cancer Hospital, Taiyuan, China., Wang J; Department of Internal Medicine, Anyang Cancer Hospital, Anyang, China., Deng W; Department of Gastroenterology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Guo W; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Jia T; Department of Oncology, ZiBo Central Hospital, Zibo, China., Jiang D; Department of Oncology, The Fourth Hospital of Hebei Medical University & Hebei Cancer Hospital, Shijiazhuang, China., Zhang G; Department of Oncology, Xinxiang Central Hospital, Xinxiang, China., He Y; Department of Oncology, The First Affiliated Hospital of USTC West District & Anhui Provincial Cancer Hospital, Hefei, China., Ba Y; Department of Digestive Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China., Zhong H; Department of Medical Oncology, Zhejiang Cancer Hospital, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China., Wang L; Department of Oncology, Cancer Center of Jinling Hospital, Nanjing University of Chinese Medicine, No. 34 Biao, 34 Hao, Yanggongjing Road, Qinhuai District, Nanjing, 210002, Jiangsu Province, China., Lin X; Department of Medical Oncology, Fujian Medical University Affiliated Union Hospital, Fuzhou, China., Yang J; Department of Abdominal Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China., Zhao J; Department of Oncology, Changzhi People's Hospital, Changzhi, China., Bai Y; Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Wu X; Department of Oncology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China., Gao F; Department of Oncology, Heilongjiang Agricultural Reclamation Bureau General Hospital, Harbin, China., Sun G; Department of Radiotherapy and Chemotherapy, Tangshan People's Hospital, Tangshan, China., Wu Y; Department of Digestive Oncology, Baotou Tumor Hospital, Baotou, China., Ye F; Department of Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Wang Q; Department of Oncology, Jiangyin People's Hospital, Jiangyin, China., Xie Z; Department of Oncology, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China., Yi T; Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China., Huang Y; Department of Oncology, The Second People's Hospital of Hefei, Hefei, China., Yu G; Department of Oncology, Weifang People's Hospital, Weifang, China., Lu L; Department of Oncology, 105 Hospital of People's Liberation Army, Hefei, China., Yuan Y; Department of Oncology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China., Li W; Department of Oncology, The First Hospital of Jilin University, Changchun, China., Liu L; Department of Oncology, Shanxi Traditional Chinese Medical Hospital, Taiyuan, China., Sun Y; Department of Oncology, Central Hospital Affiliated To Shandong First Medical University, Jinan, China., Sun Y; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China., Yin L; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China., Hou Z; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.

المصدر: BMC medicine [BMC Med] 2023 May 05; Vol. 21 (1), pp. 173. Date of Electronic Publication: 2023 May 05.

نوع المنشور: Clinical Trial, Phase IV; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/adverse effects , Stomach Neoplasms*/drug therapy , Adenocarcinoma*/drug therapy , Adenocarcinoma*/pathology, Humans ; Prospective Studies ; Esophagogastric Junction/pathology

SCR Disease Name: Adenocarcinoma Of Esophagus

المؤلفون: Huang JQ; Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China.; Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Carson International Cancer Center, and Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China.; School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China., Duan LX; Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China.; School of Pharmaceutical Sciences, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China., Liu QY; Department of Pathology, Henan Provincial People's Hospital, The People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, P.R. China., Li HF; Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China.; School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China., Hu AP; Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China., Song JW; Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China.; Medical School, Southern University of Science and Technology, Shenzhen, Guangdong, 518005, P.R. China., Lin C; Medical AI Lab, School of Biomedical Engineering, Shenzhen University Medical School, 518055, Shenzhen, Guangdong, P.R. China., Huang B; Medical AI Lab, School of Biomedical Engineering, Shenzhen University Medical School, 518055, Shenzhen, Guangdong, P.R. China., Yao D; Department of Thoracic Surgery, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, P.R. China., Peng B; Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Carson International Cancer Center, and Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China., Sun Y; Department of Clinical Pharmacy, Shenzhen Traditional Chinese Medicine Hospital, 4th Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, 518005, P.R. China., Wen Y; Department of Thoracic Surgery, Shenzhen People's Hospital, 2nd Clinical Medical College of Jinan University, Shenzhen, Guangdong, 518020, P.R. China., Yang L; Department of Thoracic Surgery, Shenzhen People's Hospital, 2nd Clinical Medical College of Jinan University, Shenzhen, Guangdong, 518020, P.R. China., Xu X; Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Carson International Cancer Center, and Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China., Gong LY; Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shenzhen University Medical School, Shenzhen, Guangdong, 518055, P.R. China. gongly@szu.edu.cn.

المصدر: Oncogene [Oncogene] 2023 Apr; Vol. 42 (15), pp. 1233-1246. Date of Electronic Publication: 2023 Mar 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/metabolism , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/metabolism , Arginine Kinase*/metabolism , Arginine Kinase*/therapeutic use , Antineoplastic Agents*/pharmacology, Humans ; Gefitinib/pharmacology ; Gefitinib/therapeutic use ; Phosphorylation ; Protein Serine-Threonine Kinases/metabolism ; Protein Kinases/metabolism ; Glycogen Synthase Kinase 3 beta/genetics ; Glycogen Synthase Kinase 3 beta/metabolism ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Drug Resistance, Neoplasm/genetics ; ErbB Receptors/metabolism ; Cell Line, Tumor

المؤلفون: Song D; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.; School of Humanities and Management, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China., Liang JJ; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China., Pu SB; College of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, China., Zhang PP; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China., Peng YL; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China., Liu X; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China., Feng TT; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China., Pu X; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China., Zhou Y; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China., Liu XW; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China., Wei X; School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.

المصدر: Molecules (Basel, Switzerland) [Molecules] 2023 Mar 10; Vol. 28 (6). Date of Electronic Publication: 2023 Mar 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

مواضيع طبية MeSH: Gelsemium*/chemistry , Secologanin Tryptamine Alkaloids*/pharmacology , Secologanin Tryptamine Alkaloids*/chemistry , Antineoplastic Agents*/pharmacology, Molecular Structure ; Indoles ; Plant Extracts/pharmacology ; Indole Alkaloids/chemistry

المؤلفون: Wang W; Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China., Liu D; Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China., Yang L; Department of Biochemistry and Molecular Biology, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China., Chen L; Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China., Miao M; Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China., Liu Y; Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China., Yin Y; Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China., Wei M; Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China., Liu G; Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China., An Y; Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China., Zheng M; Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China.

المصدر: International journal of molecular medicine [Int J Mol Med] 2023 Mar; Vol. 51 (3). Date of Electronic Publication: 2023 Feb 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9810955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-244X (Electronic) Linking ISSN: 11073756 NLM ISO Abbreviation: Int J Mol Med Subsets: MEDLINE

مواضيع طبية MeSH: Heart Failure*/drug therapy , Heart Failure*/metabolism , Antineoplastic Agents*/pharmacology, Mice ; Animals ; Male ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction ; Phosphatidylinositol 3-Kinases/metabolism ; Myocytes, Cardiac/metabolism ; Angiotensin II/pharmacology ; Angiotensin II/metabolism ; Mice, Inbred C57BL ; Apoptosis Regulatory Proteins/metabolism ; Apoptosis

المؤلفون: Wang H; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China., Chu F; Department of Emergency, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China., Zhang XF; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China., Zhang P; Department of Urology, Chinese People's Liberation Army (PLA) General Hospital/Chinese PLA Medical Academy, Beijing, 100853, China., Li LX; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China., Zhuang YL; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China., Niu XF; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China., He X; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China., Li ZJ; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China., Bai Y; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China., Mao D; Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing, 100191, China.; Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing, 100029, China., Liu ZW; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China. 13911395948@139.com., Zhang DL; Senior Department of Hepatology, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China. zhangdali20051019@163.com., Li BA; Clinical Laboratory, the Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, 100039, China. lba@263.net.

المصدر: Cell death & disease [Cell Death Dis] 2023 Jan 27; Vol. 14 (1), pp. 64. Date of Electronic Publication: 2023 Jan 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/genetics , Carcinoma, Hepatocellular*/metabolism , Liver Neoplasms*/drug therapy , Liver Neoplasms*/genetics , Liver Neoplasms*/metabolism , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use, Humans ; Pregnane X Receptor/genetics ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; Transcription Factors/therapeutic use ; Cytochrome P-450 CYP3A/genetics ; Microtubule-Associated Proteins/genetics ; Cell Cycle Proteins/genetics

المؤلفون: Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, People's Republic of China. Electronic address: syuankai@cicams.ac.cn., Li B; Integrated Department, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China., Wu L; Department of Medical Oncology-Chest (2), Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China., Pan Y; Cancer Chemotherapy Department, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Hefei, People's Republic of China., Pan Z; Department of Respiratory Diseases, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China., Liu Y; Department of Medical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China., Fan Y; Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China., Ji Y; Medical Oncology Ward 2, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, People's Republic of China., Fang J; Department of Thoracic Oncology II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/ Beijing), Peking University Cancer Hospital and Institute, Beijing, People's Republic of China., Shi Q; Oncology Department, Fuzhou Pulmonary Hospital of Fujian, Fuzhou, People's Republic of China., Shi J; Department II of Medical Oncology, Linyi Cancer Hospital, Linyi, People's Republic of China., Gao H; Pulmonary Oncology Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China., Hu Y; Department of Thoracic Oncology, Hubei Cancer Hospital, The Affiliated Cancer Hospital of Tongji School of Medicine, Huazhong University of Science and Technology, Wuhan, People's Republic of China., Wang X; Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou, People's Republic of China., He Z; Department of Thoracic Oncology, Fujian Cancer Hospital, The Affiliated Cancer Hospital of Fujian Medical University, Fuzhou, People's Republic of China., Ma R; Department II of Chest Physicians, Liaoning Cancer Hospital & Institute, Shenyang, People's Republic of China., Zhang Y; Department I of Respiratory Medicine, Nanjing Chest Hospital, Medical School of Southeast University, Nanjing, People's Republic of China., Jiang D; Medical of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China., Bai Y; Oncology Hematology Department, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China., Zhang Y; Thoracic Surgery Department, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China., Huang L; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, People's Republic of China., Zhou T; Oncology Department, Changzhou Tumor Hospital, Changzhou, People's Republic of China., Liu H; Department of Thoracic Medical Oncology, First People's Hospital of Chenzhou City, Chenzhou, People's Republic of China., Wang D; Department of Medical Oncology, Harrison International Peace Hospital, Hengshui, People's Republic of China., Wen Q; Oncology Department, The Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China., Chen G; Department of Medical Oncology, Tumor Hospital of Harbin Medical University, Harbin, People's Republic of China., Zang A; Medicine Oncology, Affiliated Hospital of Hebei University, Baoding, People's Republic of China., Wang X; Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, People's Republic of China., Zhang X; Department of Respiratory and Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China., Hu J; Oncology Department, Yueyang Central hospital, Yueyang, People's Republic of China., Yang R; Internal Second Department, Yunnan Cancer hospital, Kunming, People's Republic of China., Zhang G; Department 1 of Pulmonary & Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Gu K; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China., Wang L; Department of Medical Oncology, Hainan General Hospital, Haikou, People's Republic of China., Wang Q; Department of Medical Oncology, Henan Cancer Hospital, Zhengzhou, People's Republic of China., Wei Z; Pulmonary and Critical Care Medicine Department, The People's Hospital of Nanchuan, Chongqing, People's Republic of China., Li Z; Department of Oncology, 3201 Hospital, Hanzhong, People's Republic of China., Lu H; Department of Oncology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China., Zhang H; Department of Oncology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, People's Republic of China., Chen H; Jiangsu Aosaikang Pharmaceutical Co. Ltd., Nanjing, People's Republic of China., Song T; Jiangsu Aosaikang Pharmaceutical Co. Ltd., Nanjing, People's Republic of China.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Oct; Vol. 17 (10), pp. 1205-1215. Date of Electronic Publication: 2022 Jun 02.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/adverse effects , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Exanthema* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, Acrylamides ; Aniline Compounds/therapeutic use ; Diarrhea/chemically induced ; ErbB Receptors ; Humans ; Mutation ; Protein Kinase Inhibitors/adverse effects

المؤلفون: Liu Z; Department of Oncology, Zhoushan Hospital of Traditional Chinese Medicine, Zhoushan, 316000 Zhejiang, China., Ding Y; Department of Nutrition and Medical Insurance Price Office, Zhoushan Hospital of Traditional Chinese Medicine, Zhoushan, 316000 Zhejiang, China., Tian Y; Department of Oncology, Zhoushan Hospital of Traditional Chinese Medicine, Zhoushan, 316000 Zhejiang, China., Yu D; Department of Oncology, Zhoushan Hospital of Traditional Chinese Medicine, Zhoushan, 316000 Zhejiang, China.

المصدر: Computational and mathematical methods in medicine [Comput Math Methods Med] 2022 Jul 21; Vol. 2022, pp. 9089365. Date of Electronic Publication: 2022 Jul 21 (Print Publication: 2022).

نوع المنشور: Journal Article; Retracted Publication

بيانات الدورية: Publisher: Hindawi Country of Publication: United States NLM ID: 101277751 Publication Model: eCollection Cited Medium: Internet ISSN: 1748-6718 (Electronic) Linking ISSN: 1748670X NLM ISO Abbreviation: Comput Math Methods Med Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma of Lung*/drug therapy , Adenocarcinoma of Lung*/genetics , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, Apoptosis ; Cell Line, Tumor ; Cisplatin/pharmacology ; Cisplatin/therapeutic use ; Drug Resistance, Neoplasm/genetics ; Ethanol/pharmacology ; Ethanol/therapeutic use ; Humans

المؤلفون: Xing S; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Nong F; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Wang Y; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Huang D; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Qin J; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Chen YF; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., He DH; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Wu PE; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Huang H; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Zhan R; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Xu H; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China., Liu YQ; Research Center of Chinese Herbal Resources Science and Engineering, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Key Laboratory of Chinese Medicinal Resource from Lingnan, Ministry of Education, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. Electronic address: liuyq@gzucm.edu.cn.

المصدر: Pharmacological research [Pharmacol Res] 2022 Feb; Vol. 176, pp. 106059. Date of Electronic Publication: 2022 Jan 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1186 (Electronic) Linking ISSN: 10436618 NLM ISO Abbreviation: Pharmacol Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Biotin/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy , Quassins/*therapeutic use , S-Phase Kinase-Associated Proteins/*antagonists & inhibitors, Animals ; Antineoplastic Agents/pharmacology ; Biotin/pharmacology ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line ; Humans ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Male ; Mice, Inbred BALB C ; Mice, Nude ; Quassins/pharmacology ; S-Phase Kinase-Associated Proteins/genetics ; S-Phase Kinase-Associated Proteins/metabolism ; Mice

المؤلفون: Tian M; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China., Chen XS; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China., Li LY; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China., Wu HZ; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China., Zeng D; Department of Gynecology and Obstetrics, The Third Xiangya Hospital, Central South University, Changsha, 410008, China., Wang XL; Translational Medicine R&D Center, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518057, China., Zhang Y; Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215000, China., Xiao SS; Department of Gynecology and Obstetrics, The Third Xiangya Hospital, Central South University, Changsha, 410008, China. xiaosongshu@csu.edu.cn., Cheng Y; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China. yancheng@csu.edu.cn.

المصدر: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2021 Jul; Vol. 42 (7), pp. 1180-1189. Date of Electronic Publication: 2020 Nov 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Cisplatin/*therapeutic use , Glycolysis/*physiology , Ovarian Neoplasms/*drug therapy , Proto-Oncogene Proteins/*metabolism , Receptor Protein-Tyrosine Kinases/*metabolism, Animals ; Antineoplastic Agents/pharmacology ; Benzocycloheptenes/pharmacology ; Benzocycloheptenes/therapeutic use ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cisplatin/pharmacology ; Deoxyglucose/pharmacology ; Deoxyglucose/therapeutic use ; Drug Resistance, Neoplasm/drug effects ; Drug Screening Assays, Antitumor ; Female ; Glycolysis/drug effects ; HEK293 Cells ; Humans ; Mice, Nude ; Ovarian Neoplasms/pathology ; Protein Kinase Inhibitors/therapeutic use ; Triazoles/pharmacology ; Triazoles/therapeutic use ; Xenograft Model Antitumor Assays ; Axl Receptor Tyrosine Kinase ; Mice